Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysis

Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysis

Summary: Background: Summarized data of cardiovascular outcomes trials (CVOTs) of sodium glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have shown a reduction in major adverse cardiovascular event (MACE), whether these benefits are extended in...

Full description

Bibliographic Details
Main Authors: Alhassane Diallo, Miguel Carlos-Bolumbu, Florence Galtier
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:EClinicalMedicine
Subjects:
Meta-analysis
Risk group differences
MACE
CVOTs
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537022004278

Internet

http://www.sciencedirect.com/science/article/pii/S2589537022004278

Similar Items